The results of this systematic review and meta-analysis provide important evidence regarding the relationship between several biomarkers and the risk of CVD events and mortality in middle-aged asymptomatic adults with autoimmune diseases, most notably hs-CRP, lupus anticoagulant, sVCAM-1, and aPL antibodies. The gene discussed is FASLG; the disease is autoimmune disease.